Deutsche Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$968K Buy
3,472
+830
+31% +$239K ﹤0.01% 2198
2025
Q4
$801K Buy
2,642
+678
+35% +$212K ﹤0.01% 2313
2025
Q3
$551K Buy
1,964
+478
+32% +$130K ﹤0.01% 2493
2025
Q2
$359K Sell
1,486
-29,471
-95% -$6.97M ﹤0.01% 2627
2025
Q1
$7.54M Sell
30,957
-6,644
-18% -$2M ﹤0.01% 1101
2024
Q4
$12.4M Buy
37,601
+1,027
+3% +$349K ﹤0.01% 962
2024
Q3
$12.2M Sell
36,574
-53,885
-60% -$17.1M 0.01% 965
2024
Q2
$24.7M Sell
90,459
-15,992
-15% -$4.65M 0.01% 752
2024
Q1
$36.8M Buy
106,451
+14,110
+15% +$4.64M 0.02% 639
2023
Q4
$29.8M Buy
92,341
+28,099
+44% +$8.81M 0.02% 676
2023
Q3
$23M Sell
64,242
-24,123
-27% -$9.31M 0.01% 671
2023
Q2
$33.5M Buy
88,365
+22,699
+35% +$9.24M 0.02% 620
2023
Q1
$31.5M Buy
65,666
+3,559
+6% +$1.67M 0.02% 643
2022
Q4
$26.1M Buy
62,107
+10,986
+21% +$4.43M 0.02% 689
2022
Q3
$21.3M Sell
51,121
-34,031
-40% -$17M 0.01% 741
2022
Q2
$42.1M Buy
85,152
+19,300
+29% +$10.1M 0.02% 566
2022
Q1
$37.1M Sell
65,852
-121
-0.2% -$72.9K 0.02% 675
2021
Q4
$49.8M Sell
65,973
-9,474
-13% -$7.09M 0.02% 589
2021
Q3
$56.3M Sell
75,447
-100,437
-57% -$75.2M 0.03% 558
2021
Q2
$113M Buy
175,884
+3,963
+2% +$2.41M 0.06% 342
2021
Q1
$98.2M Buy
171,921
+116,665
+211% +$69.1M 0.05% 357
2020
Q4
$32.2M Sell
55,256
-9,162
-14% -$5.22M 0.02% 641
2020
Q3
$33.2M Buy
64,418
+29,210
+83% +$14.8M 0.02% 564
2020
Q2
$15.9M Buy
35,208
+15,864
+82% +$7M 0.01% 781
2020
Q1
$6.78M Sell
19,344
-21,185
-52% -$7.79M 0.01% 1089
2019
Q4
$15M Sell
40,529
-108,481
-73% -$38.2M 0.01% 902
2019
Q3
$49.6M Sell
149,010
-65,952
-31% -$21.5M 0.03% 481
2019
Q2
$67.2M Buy
214,962
+43,143
+25% +$12.9M 0.04% 466
2019
Q1
$52.5M Buy
171,819
+111,962
+187% +$30.2M 0.03% 564
2018
Q4
$13.9M Sell
59,857
-128,963
-68% -$34.6M 0.01% 1096
2018
Q3
$59.1M Sell
188,820
-33,159
-15% -$10.3M 0.03% 585
2018
Q2
$64M Buy
221,979
+71,392
+47% +$19.7M 0.03% 571
2018
Q1
$37.7M Buy
150,587
+58,557
+64% +$14.9M 0.02% 761
2017
Q4
$22M Buy
92,030
+64,016
+229% +$15.5M 0.01% 950
2017
Q3
$6.22M Sell
28,014
-18,896
-40% -$4.25M ﹤0.01% 1774
2017
Q2
$10.6M Sell
46,910
-13,669
-23% -$2.98M 0.01% 1362
2017
Q1
$12.1M Buy
60,579
+29,803
+97% +$5.74M 0.01% 1145
2016
Q4
$5.61M Sell
30,776
-2,294
-7% -$391K ﹤0.01% 1602
2016
Q3
$5.42M Sell
33,070
-14,327
-30% -$2.17M ﹤0.01% 1675
2016
Q2
$6.78M Sell
47,397
-28,501
-38% -$4.07M ﹤0.01% 1544
2016
Q1
$10.4M Buy
75,898
+21,122
+39% +$2.77M 0.01% 1244
2015
Q4
$7.59M Buy
54,776
+4,757
+10% +$659K 0.01% 1507
2015
Q3
$6.72M Buy
50,019
+39,271
+365% +$5.65M 0.01% 1573
2015
Q2
$1.62M Sell
10,748
-26,501
-71% -$3.79M ﹤0.01% 2632
2015
Q1
$5.03M Buy
37,249
+13,530
+57% +$1.68M ﹤0.01% 1781
2014
Q4
$2.86M Sell
23,719
-5,493
-19% -$632K ﹤0.01% 2390
2014
Q3
$3.31M Sell
29,212
-3,577
-11% -$424K ﹤0.01% 2128
2014
Q2
$3.92M Buy
32,789
+2,110
+7% +$258K ﹤0.01% 2003
2014
Q1
$3.93M Sell
30,679
-2,616
-8% -$335K ﹤0.01% 1986
2013
Q4
$4.12M Sell
33,295
-2,968
-8% -$362K ﹤0.01% 1882
2013
Q3
$4.26M Sell
36,263
-26,097
-42% -$3.08M ﹤0.01% 1941
2013
Q2
$7M Buy
+62,360
New +$7.31M 0.01% 1425

Other funds holding BIO